Significance The importance of circadian rhythm in health is evident in studies from metabolic disorders to Alzheimer’s disease. However, translating these observations to the clinic remains stymied due to the burden of measuring physiological time. Methods to assess physiological time using blood biomarkers address this issue, but they must be accurate and generalizable across protocols and platforms. Here, we present TimeMachine, an algorithm that can estimate the circadian phase from a single blood sample. Validation on four distinct datasets shows TimeMachine accurately recovers phase estimates from a single-timepoint gene expression profile of human peripheral blood mononuclear cells across varied protocols and technologies, an important advance over current methods. This algorithm offers a feasible approach for incorporating circadian biomarkers in research and clinical care.
Platform-independent estimation of human physiological time from single blood samples
Published 2024 in Proceedings of the National Academy of Sciences of the United States of America
ABSTRACT
PUBLICATION RECORD
- Publication year
2024
- Venue
Proceedings of the National Academy of Sciences of the United States of America
- Publication date
2024-01-08
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-34 of 34 references · Page 1 of 1
CITED BY
Showing 1-16 of 16 citing papers · Page 1 of 1